Anglopharma: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
Anglopharma
Largest movements
- Receivables within one year +€28,625
up €28,625 (+35.0%), from €81,891 to €110,516
of which Trade receivables: +€30,715
- Current investments -€16,814
down €16,814 (-30.6%), from €54,865 to €38,052
- Cash +€15,476
up €15,476 (+7.4%), from €208,153 to €223,629
mainly Trade debts (+€20,091) and Current investments (+€16,814)
- Reserves -€21,935
down €21,935 (-27.3%), from €80,454 to €58,519
of which Distributable reserves: -€21,935
- Trade debts +€20,091
up €20,091 (+28.1%), from €71,415 to €91,506
- Profit (loss) carried forward +€15,526
up €15,526 (+3.8%), from €410,430 to €425,956
- Tax, wage and social debts +€12,061
up €12,061 (+51.0%), from €23,626 to €35,687
of which Taxes: +€9,394
- Gross operating margin -€28,700
down €28,700 (-14.0%), from €204,937 to €176,237
- Depreciation -€13,186
down €13,186 (-74.9%), from €17,595 to €4,409
- Taxes -€3,974
down €3,974 (-30.8%), from €12,903 to €8,930
From the 2025 result to the 2026 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2025 and 2026 balance sheets and the 2026 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2025 | 2026 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €644,004 | €669,817 | +€25,813 | +4.0% |
| Fixed assets | 21/28 | €105,245 | €106,190 | +€944 | +0.9% |
| Tangible fixed assets | 22/27 | €105,052 | €105,996 | +€944 | +0.9% |
| Land and buildings | 22 | €99,578 | €97,828 | -€1,750 | -1.8% |
| Plant, machinery and equipment | 23 | €3,524 | €2,310 | -€1,214 | -34.4% |
| Furniture and vehicles | 24 | €1,950 | €5,858 | +€3,908 | +200% |
| Financial fixed assets | 28 | €194 | €194 | = | 0.0% |
| Current assets | 29/58 | €538,758 | €563,628 | +€24,869 | +4.6% |
| Stocks and contracts in progress | 3 | €188,644 | €182,892 | -€5,751 | -3.0% |
| Stocks | 30/36 | €188,644 | €182,892 | -€5,751 | -3.0% |
| Amounts receivable within one year | 40/41 | €81,891 | €110,516 | +€28,625 | +35.0% |
| Trade receivables | 40 | €59,585 | €90,301 | +€30,715 | +51.5% |
| Other amounts receivable | 41 | €22,306 | €20,216 | -€2,090 | -9.4% |
| Current investments | 50/53 | €54,865 | €38,052 | -€16,814 | -30.6% |
| Cash at bank and in hand | 54/58 | €208,153 | €223,629 | +€15,476 | +7.4% |
| Deferred charges and accrued income | 490/1 | €5,205 | €8,538 | +€3,333 | +64.0% |
| Total equity and liabilities | 10/49 | €644,004 | €669,817 | +€25,813 | +4.0% |
| Equity | 10/15 | €510,891 | €504,483 | -€6,408 | -1.3% |
| Contributions | 10/11 | €20,007 | €20,007 | = | 0.0% |
| Reserves | 13 | €80,454 | €58,519 | -€21,935 | -27.3% |
| Non-distributable reserves | 130/1 | €38,052 | €38,052 | = | 0.0% |
| Reserves not available under the articles | 1311 | €38,052 | €38,052 | = | 0.0% |
| Tax-exempt reserves | 132 | €2,902 | €2,902 | = | 0.0% |
| Distributable reserves | 133 | €39,499 | €17,565 | -€21,935 | -55.5% |
| Profit (loss) carried forward | 14 | €410,430 | €425,956 | +€15,526 | +3.8% |
| Amounts payable | 17/49 | €133,113 | €165,334 | +€32,222 | +24.2% |
| Amounts payable within one year | 42/48 | €133,113 | €163,598 | +€30,485 | +22.9% |
| Trade debts | 44 | €71,415 | €91,506 | +€20,091 | +28.1% |
| Suppliers | 440/4 | €71,415 | €91,506 | +€20,091 | +28.1% |
| Taxes, remuneration and social security | 45 | €23,626 | €35,687 | +€12,061 | +51.0% |
| Taxes | 450/3 | €1,395 | €10,790 | +€9,394 | +673% |
| Remuneration and social security | 454/9 | €22,231 | €24,897 | +€2,666 | +12.0% |
| Other amounts payable | 47/48 | €38,072 | €36,405 | -€1,666 | -4.4% |
| Accrued charges and deferred income | 492/3 | - | €1,737 | +€1,737 | |
| Remuneration, social security and pensions | 62 | €131,793 | €133,694 | +€1,901 | +1.4% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €17,595 | €4,409 | -€13,186 | -74.9% |
| Write-downs on stocks, contracts in progress and trade receivables: additions (reversals) | 631/4 | €7,349 | €7,250 | -€99 | -1.3% |
| Other operating charges | 640/8 | €1,447 | €1,103 | -€343 | -23.7% |
| Non-recurring operating charges | 66A | €110,908 | - | -€110,908 | |
| Gross operating margin | 9900 | €204,937 | €176,237 | -€28,700 | -14.0% |
| Operating profit (loss) | 9901 | -€64,154 | €29,781 | +€93,935 | |
| Financial income | 75/76B | €2,169 | €2,637 | +€467 | +21.6% |
| Recurring financial income | 75 | €2,169 | €2,637 | +€467 | +21.6% |
| Financial charges | 65/66B | €8,202 | €7,962 | -€241 | -2.9% |
| Recurring financial charges | 65 | €8,202 | €7,962 | -€241 | -2.9% |
| Profit (loss) for the period before taxes | 9903 | -€70,187 | €24,456 | +€94,643 | |
| Income taxes | 67/77 | €12,903 | €8,930 | -€3,974 | -30.8% |
| Profit (loss) for the period | 9904 | -€83,090 | €15,526 | +€98,616 | |
| Profit (loss) for the period to be appropriated | 9905 | -€83,090 | €15,526 | +€98,616 |
Source: filed annual accounts (NBB), financial years ended 31 January 2025 and 31 January 2026. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 17 October 2026 via checked.be.